View Article

Abstract

Dementia is a clinical diagnosis requiring new functional dependence based on progressive cognitive decline. It is estimated that 1.3% of the entire UK population, or 7.1% of those aged 65 or over, have dementia. Applying these to 2013 population estimates gives an estimated number of 19,765 people living with dementia in Northern Ireland. The clinical syndrome of dementia can be due to a variety of underlying pathophysiological processes. The most common of these is Alzheimer's disease (50 75%) followed by vascular dementia (20%), dementia with Lewy bodies (5%), and front temporal lobar dementia (5%). The clinical symptoms and pathophysiological processes of these diseases overlap significantly. Biomarkers to aid diagnosis and prognosis are emerging. Acetylcholinesterase inhibitors and meantime are the only medications currently licensed for the treatment of dementia. The nature of symptoms means people with dementia are more dependent and vulnerable, both socially and in terms of physical and mental health, presenting evolving challenges to society and to our healthcare systems.

Keywords

Alzheimer's disease, Vascular dementia Lewy body dementia, Front temporal dementia, Mixed dementia

Introduction

Dementia is a progressive neurological disorder characterized by a decline in cognitive function that interferes with daily activities and quality of life. It is not a specific disease but rather a syndrome that encompasses a range of symptoms associated with a loss of brain function. The most common form of dementia is Alzheimer's disease, accounting for approximately 60   70% of cases, followed by vascular dementia, Lewy body dementia, and other less common types. Dementia means" To depart from mind "in Latin. Dementia is a condition that is described as a decrease in brain function. To have dementia your brain function two needs to become deficient in at least two areas The facets are of brain activity that may affected by dementia memory ore thinking Judgment, behaviour, and language Besides this dementia is not a disease but a condition caused by another illness or injury. some types of dementia are progressive and can get worse over time The condition can result in mild to serious mental impairment. However, some types are treatable or reversible if you get the right kind of medical help early. The hallmark feature of dementia is memory loss, which also involves difficulties with language, problem-solving, and decision-making. As the condition advances, individuals may experience behavior, personality, and mood changes. Dementia not only affects the individual diagnosed but also places a significant burden on family members and caregivers who provide support and assistance. The causes of dementia are complex and multifactorial, involving genetic predisposition, age-related changes in the brain, and environmental factors. While there is currently no cure for dementia, early diagnosis and appropriate management strategies can help slow the progression of symptoms and improve the quality of life for affected individuals.

Given the increasing prevalence of dementia worldwide, there is a growing need for research to better understand the underlying mechanisms of the condition, develop more effective treatments, and enhance support services for patients and caregivers. This review paper aims to provide an overview of dementia, including its causes, symptoms, diagnosis, treatment options, and impact on individuals and families, as well as explore current research trends and future directions in dementia care.

Types

Dementia is an umbrella term for a range of cognitive impairments that interfere with daily functioning. Some common types include:

1. Alzheimer's disease: Characterized by progressive memory loss, confusion, and difficulties with language and reasoning.

2. Vascular dementia: Caused by reduced blood flow to the brain, leading to symptoms such as difficulties with reasoning, judgment, and planning.

3. Lewy body dementia: Symptoms include visual hallucinations, fluctuating cognition, and problems with movement, similar to Parkinson's disease.

4. Frontotemporal dementia: Affecting the frontal and temporal lobes of the brain, leading to changes in personality, behaviour, and language difficulties.

5. Mixed dementia:This occurs when a person has more than one type of dementia, such as a combination of Alzheimer's and vascular dementia.

These are just a few examples, and there are other less common types as well. Each ty pe may have different causes, symptoms, and progression patterns.

Certainly, here are some additional types of dementia:

1. Creutzfeldt   Jakob disease (CJD): A rare, degenerative brain disorder that leads to rapidly progressive dementia, muscle stiffness, and involuntary movements.

2. Huntington's disease: A genetic disorder that causes progressive breakdown of nerve cells in the brain, resulting in cognitive decline, movement disorders, and psychiatric symptoms.

3. Parkinson's disease dementia: A condition in which individuals with Parkinson's disease develop cognitive impairment, including memory loss, executive dysfunction, and difficulties with language and visuospatial skills.

4. Wernicke   Korsakoff syndrome: Often caused by chronic alcohol abuse, this condition involves a deficiency in thiamine (vitamin B1), leading to severe memory impairment, confusion, and neurological symptoms.

5. Normal pressure hydrocephalus (NPH): Characterized by an accumulation of cerebrospinal fluid in the brain's ventricles, leading to symptoms such as cognitive decline, gait disturbances, and urinary incontinence.

These are some of the less common types of dementia, each with its own unique set of symptoms, causes, and treatment approaches.

Dementia typically progresses through several stages, each with its own set of symptoms and challenges. While the exact progression can vary depending on the individual and the type of dementia they have, here's a general overview:

1. Early Stage (Mild Cognitive Impairment): In this stage, symptoms may be subtle and may not be immediately noticeable to the individual or their loved ones. However, there may be occasional memory lapses, difficulty finding the right words, and mild changes in mood or behaviour. Daily activities can still be managed independently, but there may be some difficulties with complex tasks or planning.

2. Middle Stage (Moderate Dementia): This stage is typically the longest and can last for several years. Symptoms become more pronounced, with noticeable declines in memory, language, reasoning, and sensory perception. Individuals may struggle with everyday tasks such as dressing, bathing, and managing finances. Personality changes and behavioural symptoms such as agitation, wandering, and hallucinations may also emerge.

3. Late Stage (Severe Dementia): In the late stage, individuals require full   time assistance with all aspects of daily living. Communication becomes extremely difficult, and individuals may lose the ability to recognize loved ones or their surroundings. Mobility may be severely impaired, and there is an increased risk of infections, swallowing difficulties, and other medical complications. It's important to note that not everyone will experience dementia in the same way, and the progression of the disease can vary widely from person to person. Additionally, the specific symptoms and rate of decline may depend on the underlying cause of dementia. Early diagnosis and appropriate management strategies can help individuals and their families navigate the challenges of each stage more effectively.

Etiology Of Dementia

Dementia happens when there is damage to the brain cells. This damage intervenes with the capability of brain cells to help them communicate with each other. Your thinking, feeling, and behavior get impacted when your brain cells aren't normal. Dementia occurs due to the degeneration of neurons in the brain. Neurons are cells that carry messages from the brain and spinal cord in the form of impulses. The degeneration can occur due to several reasons, including diseases such as Alzheimer's

Neurodegeneration diseases responsible for dementia include:  

1. Parkinson's

2. Alzheimer's

3. Damage Caused By Chronic Alcoholism.

4. Vascular Dementia

5. Infection of the Brain

6. Tumours inside the Brain.

Other possible causes of dementia are metabolic disorders such as:  

1. Significant loss of neurons and volume in the brain

2. Neurofibrillary tangles (twisted nerve cell fibers)

3. Environmental factors: infection, metals, and toxins.

4. Deficiencies of vitamin B6, B12 and folate

5. Early depression

6. Genetic factors

7. Structural brain disorders such as subdural hematoma.

8. Hypothyroidism

9. Liver disorder.

Types of Dementia:

  1. Alzheimer’s Disease : Focus on the most common form of dementia, including its pathology, progression, and current research.
  2. Vascular Dementia: Examine the impact of cerebrovascular disease on cognitive decline.
  3. Lewy Body Dementia: Discuss the role of Lewy bodies in cognitive impairment and associated clinical features.
  4. Frontotemporal Dementia: Review the characteristics and research related to this group of dementias affecting the frontal and temporal lobes.

2. Diagnostic and Assessment Methods:

  1. Imaging Techniques: Cover advancements in neuroimaging techniques used for diagnosis and research.
  2. Biomarkers: Review the latest developments in fluid-based and imaging biomarkers for early detection.
  3. Cognitive Tests: Examine commonly used cognitive assessment tools and their effectiveness.

3. Therapeutic Approaches:

  1. Pharmacological Treatments: Analyse current drug therapies and ongoing trials.
  2. Non-Pharmacological Interventions: Review behavioral therapies, cognitive training programs, and lifestyle interventions.
  3. Emerging Therapies: Discuss new and experimental treatments under investigation.

4.  Research and Technological Advances:

  1. Innovative Technologies: Include advances in artificial intelligence, machine learning, and digital health tools contributing to research and clinical practice.
  2. Regenerative Medicine: Explore the potential of stem cells and gene therapy.

5.  Public Health and Policy:

  1. Epidemiology and Demographics: Review the impact of dementia on different populations and regions.
  2. Policy and Care Models: Assess current policies and care models, and their effectiveness in managing dementia.

6.  Ethical and Social Considerations:

  1. Ethical Issues: Address ethical concerns related to research practices, treatment decisions, and patient autonomy.
  2. Social Impact: Explore the broader social implications of dementia, including caregiver burden and societal attitudes

Sign & Symptoms

All symptoms and signs of dementia are connected to a person's cognition and psychology. These symptoms may vary with stages and types of dementia.

Here are some common symptoms:  

  1. Memory Loss, Which Is Usually Noticed By Someone Else
  2. Personality Changes
  3. Feeling Anger Frequently
  4. Difficulty Communicating Or Finding Words
  5. Struggling To Express Ideas And Emotions
  6. Difficulty Reasoning Or Problem-Solving
  7. Forgetfulness
  8. Depression

Moderate dementia symptoms are more serious and might require help from others to deal with them including

  1. Poor judgment
  2. Significant personality and mood changes
  3. Significant large memory loss
  4. Increase frustration and confusion
  5. Inability to perform simple tasks such as bathing, teething, etc.

Mental faculties continue to decline in severe dementia. leading to symptoms such as

  1. Inability to communicate
  2. Inability to perform regular bodily functions
  3. Greater risk of infection
  4. Requiring help for all kinds of daily activities

       
            fig 1.jpg
       

While there's no guaranteed way to prevent dementia, certain lifestyle choices and habits may reduce the risk or delay its onset

1. Stay Physically Active: Regular exercise, such as walking, swimming, or gardening, can help maintain brain health and reduce the risk of cognitive decline.

2. Healthy Diet: Eating a balanced diet rich in fruits, vegetables, whole grains, lean proteins, and healthy fats can support brain health. Some studies suggest that a Mediterranean diet, which includes fish, olive oil, and nuts, may be particularly beneficial.

3. Maintain Social Connections: Engaging in social activities and maintaining strong social networks may help protect against cognitive decline.

4. Keep Mentally Stimulated: Activities that challenge the brain, such as puzzles, reading, learning a new skill, or playing musical instruments, can help maintain cognitive function.

5. Manage Chronic Conditions: Conditions such as high blood pressure, diabetes, obesity, and high cholesterol can increase the risk of dementia. Managing these conditions through lifestyle changes and medication, if necessary, may help reduce the risk.

6. Get Quality Sleep: Aim for 7   8 hours of quality sleep per night, as sleep plays a crucial role in brain health and cognitive function.

7. Limit Alcohol Consumption: Excessive alcohol consumption can increase the risk of dementia. Limiting alcohol intake to moderate levels is recommended.

8. Quit Smoking: Smoking is associated with an increased risk of dementia. Quitting smoking can improve overall health and reduce the risk of cognitive decline.

9. Manage Stress: Chronic stress can negatively impact brain health. Finding healthy ways to manage stress, such as meditation, yoga, or spending time in nature, may be beneficial.

By incorporating these habits into daily life, individuals can help reduce their risk of developing dementia and support overall brain health as they age.

DIAGNOSIS TEST  

1. Medical History and Physical Examination: The doctor will review the individual's medical history, including family history of dementia, and conduct a physical exam to assess overall health and neurological function.

2. Cognitive and Neuropsychological Tests: These tests evaluate memory, language skills, problem-solving abilities, and other cognitive functions. Common tests include the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA).

3. Laboratory Tests: Blood tests can help rule out other conditions that may cause similar symptoms, such as vitamin deficiencies or thyroid problems.

4. Brain Imaging: Imaging tests such as MRI or CT scans can reveal changes in the brain structure that may indicate dementia, such as shrinkage or the presence of lesions.

5. Neurological Evaluation: A neurologist may assess reflexes, muscle strength, and coordination to help rule out other neurological conditions.

6. Psychiatric Evaluation: A psychiatrist may assess mood and behavior to help differentiate between dementia and other psychiatric disorders.

7. Functional Assessment: Observing the individual's ability to perform daily tasks can provide valuable information about their cognitive function and level of impairment.

Importance of studying dementia-

Studying dementia is crucial for several reasons:

1. Prevalence and Impact: Dementia affects millions worldwide, significantly impacting individuals, families, and healthcare systems. Understanding dementia can help manage and mitigate its effects.

2. Early Detection and Diagnosis: Research improves methods for early detection and accurate diagnosis, which is vital for effective intervention and treatment.

3. Treatment Development: Studying dementia aids in the development of new therapies and interventions, potentially slowing disease progression and improving quality of life.

4. Prevention Strategies: Research helps identify risk factors and preventive measures, which could reduce the incidence of dementia.

5. Healthcare Costs: Dementia imposes substantial economic burdens on individuals and healthcare systems. Effective treatments and preventive strategies could alleviate these costs.

6. Quality of Life: Understanding dementia enhances care practices and support systems, improving the quality of life for patients and their caregivers.

7. Advancing Science: Research into dementia contributes to broader knowledge of brain function and neurodegenerative diseases, with implications for other neurological and psychiatric conditions.

Treatment Of Dementia

Treating dementia typically means making symptoms easier to live with by making them less harmful.Dementia treatment is not designed as a cure but as a way of managing the condition.Medication such as memantine and cholinesterase inhibitors are common in Alzheimer's treatment.They help patients slow down the progression of the diseases and maintain mental functions for a while longer.other treatments include changing your lifestyle to better manage dementia.you can reduce clutter in your environment to improve focus.modify common tasks into something more manageable and take part in occupational therapy.

some common approaches and strategies used in the treatment of Dementia:  

1. Medication:     certain medications can help manage cognitive symptoms and behavioural changes associated with dementia. These include cholinesterase inhibitors ( such as donepezil, rivastigmine, and galantamine) and memantine. These medications may have varying degrees of effectiveness and potential side effects, so their use should be discussed with a healthcare professional.

2. Lifestyle modification:      Encouraging a healthy lifestyle can help slow down the progression of Dementia and improve the quality of life. This includes regular physical exercise, a balanced diet, maintaining social connections, participation in mentally stimulating activities, and managing other health conditions like diabetes and hypertension.

3. Environmental modification:    creating a safe and supportive environment is important for individuals with dementia. This may involve simplifying the living space, removing Hazards, ensuring proper lighting, using visual cues, and establishing a routine to provide structure and familiarity.

4. Therapy:    Reminiscence therapy and cognitive stimulation therapy are but some of the many approaches that can help to jolt your loved one's memory. Bringing up memories from the past, playing their favourite music, and engaging in fun activities can be beneficial for loved ones with dementia, or at least brighten their day and improve their quality of life.

Objectives

1. Summarize Current Knowledge:

  1. Pathophysiology: Provide an overview of the underlying mechanisms and pathways involved in dementia, including the role of amyloid   beta plaques, tau tangles, neuroinflammation, and vascular contributions.
  2. Clinical Manifestations: Summarize the clinical features and diagnostic criteria of various types of dementia, such as Alzheimer’s disease, vascular dementia, Lewy body dementia, and frontotemporal dementia

2. Assess Diagnostic Approaches:

  1. Current Diagnostic Tools: Review the effectiveness and limitations of existing diagnostic methods, including imaging techniques (e.g., MRI, PET), biomarkers (e.g., cerebrospinal fluid, blood   based), and cognitive assessments.
  2. Early Detection: Evaluate advancements in early detection methods and biomarkers that could lead to earlier diagnosis and intervention.

3. Evaluate Therapeutic Strategies:

  1. Current Treatments: Examine the efficacy and safety of existing pharmacological treatments, such as cholinesterase inhibitors and NMDA receptor antagonists, as well as non-pharmacological interventions like cognitive training and lifestyle modifications.
  2. Innovative Therapies: Review emerging therapeutic strategies, including disease-modifying drugs, regenerative medicine (e.g., stem cell therapy), and novel approaches like neurostimulation and psychedelics.

4. Identify Research Gaps:

  1. Unresolved Questions: Highlight areas where current knowledge is insufficient or controversial, and identify gaps in understanding that need further research.
  2. Future Directions: Propose future research directions and priorities to address these gaps and improve overall dementia management.

5. Analyze Public Health Impact:

  1. Epidemiology: Review the prevalence and incidence of dementia globally and regionally, and discuss the impact of dementia on healthcare systems, caregivers, and patients.
  2. Preventive Strategies: Evaluate current strategies and public health initiatives aimed at reducing dementia risk and promoting brain health.

Risk Factors

1.   Age:  Age is the strongest risk factor for dementia. The likelihood of developing dementia doubles approximately every five years after age 65.

2.  Genetics:  Genetic factors play a role in dementia risk. For example:

Alzheimer ’s disease:  The presence of the APOE ?4 allele is associated with an increased risk.

Familial Forms:  Rare genetic mutations are linked to early-onset Alzheimer’s and other forms of dementia.

  1.  Lifestyle Factors:
  1. Cardiovascular Health:  Conditions like hypertension, diabetes, and hyperlipidaemia can increase dementia risk. Maintaining cardiovascular health through diet, exercise, and medication can help mitigate this risk.
  2. Diet and Physical Activity:  A healthy diet (e.g., Mediterranean diet) and regular physical activity are associated with a reduced risk of dementia.
  3. Smoking and Alcohol Use:  Smoking and excessive alcohol consumption are linked to an increased risk of dementia.
  4. Comorbid Conditions:  Chronic conditions such as diabetes, depression, and sleep disorders can contribute to or exacerbate cognitive decline.
  5. Education and Cognitive Engagement:  Higher levels of education and engagement in cognitively stimulating activities may reduce the risk of developing dementia, possibly due to a greater cognitive reserve.

4.   Geographic and Demographic Variations

  1. Regional Differences:  The prevalence and types of dementia can vary significantly by region. Factors include:
  2. Healthcare Access:  Variations in diagnostic practices and healthcare access can influence reported prevalence rates.

       
            fig 2.png
       

Innovative therapy approaches for dementia

Innovative therapeutic approaches for dementia are being explored across multiple dimensions of research and technology, aiming to address both the symptoms and underlying causes of this complex group of neurodegenerative disorders. Here's a detailed look at some of the most promising areas:

 1.  Biological Therapies

Biological therapies target the fundamental pathophysiological mechanisms of dementia. For Alzheimer's disease, the most common form of dementia, research is heavily focused on reducing amyloid beta plaques and tau tangles—abnormal protein accumulations that are characteristic of the disease. Amyloid   Targeting Drugs: New drugs, such as monoclonal antibodies (e.g., aducanumab, lecanemab), are designed to target and help clear amyloid beta plaques from the brain. Although these treatments have shown mixed results in clinical trials, they represent a novel approach to modifying disease progression. Tau   Targeting Strategies: Therapies that target tau protein accumulation are also under investigation. These include drugs aimed at preventing tau tangles or promoting their clearance. Recent trials have explored tau aggregation inhibitors and immunotherapies.

 2.  Gene Therapy

Gene therapy offers a cutting-edge approach to dementia treatment by modifying genetic factors involved in the disease.

  1. Gene Editing: Techniques like CRISPR/Cas9 are being studied to potentially correct genetic mutations that increase the risk of dementia. For example, researchers are investigating ways to edit genes linked to familial Alzheimer's disease.
  2. Gene Replacement: Another approach involves delivering healthy copies of genes that might be defective in dementia patients. For instance, efforts are underway to introduce genes that produce neuroprotective factors or promote neurogenesis.

 3.  Neurostimulation

Neurostimulation techniques aim to modulate brain activity to alleviate symptoms or potentially slow disease progression.

  1. Transcranial Magnetic Stimulation (TMS): This non-invasive technique uses magnetic fields to stimulate nerve cells in the brain, which can enhance cognitive function or alleviate symptoms in some patients with dementia.
  2. Deep Brain Stimulation (DBS): DBS involves implanting electrodes in specific brain regions to modulate neural activity. Although more commonly used for Parkinson’s disease, research is exploring its effects on cognitive symptoms in dementia.

   4.  Cognitive Rehabilitation

Cognitive rehabilitation focuses on improving cognitive function through structured training programs. Cognitive Training: Programs tailored to specific cognitive deficits, such as memory or executive function, are used to help patients maintain their abilities for as long as possible. Techniques include computerized cognitive training and structured problem solving tasks. Compensatory Strategies: These involve teaching patients strategies to compensate for lost cognitive functions, such as using memory aids or adaptive technologies.

 5.  Digital Health

The rise of digital health technologies provides new tools for managing dementia. Monitoring and Diagnosis: Wearable devices and mobile apps can monitor cognitive health, track behavioral changes, and aid in early diagnosis by detecting subtle changes in cognitive function. Therapeutic Apps: Apps designed for cognitive stimulation offer interactive exercises and games that can help engage patients and provide therapeutic benefits.

6.  Personalized Medicine

Personalized medicine aims to tailor treatment approaches based on an individual’s unique genetic, biological, and lifestyle factors.

  1. Genetic Profiling: By analyzing a patient’s genetic makeup, therapies can be tailored to their specific genetic risk factors. This approach helps in selecting the most effective treatments and predicting disease progression.
  2. Customized Treatment Plans: Combining genetic information with data on lifestyle and disease characteristics allows for more targeted interventions, potentially improving outcomes and reducing side effects.

 7.  Lifestyle Interventions

Lifestyle changes have been shown to impact cognitive health and may help delay or reduce the severity of dementia.

  1. Diet and Nutrition: Research into diets such as the Mediterranean diet, which is rich in antioxidants and healthy fats, suggests potential benefits for brain health and cognitive function.
  2. Physical Exercise: Regular physical activity has been consistently linked to a lower risk of cognitive decline and improved brain health. Exercise is thought to enhance neuroplasticity and reduce inflammation.
  3. Mental and Social Engagement: Activities that stimulate the brain, such as learning new skills, engaging in social interactions, and participating in meaningful activities, can also help maintain cognitive function and improve quality of life.

Future direction or research of dementia

1. Ongoing Clinical Trials and Studies

A. Clinical Trials:

  1. ADUHELM (Aducanumab):  Trials focusing on amyloid   beta plaques' impact on Alzheimer's disease.
  2. Lecanemab:  Examining the efficacy of this monoclonal antibody in reducing amyloid   beta plaques.
  3. Tau Protein Modulators:  Trials investigating therapies targeting tau protein tangles.
  4. Gene Therapy:  Exploring genetic interventions to address inherited forms of dementia.

 B. Studies:

  1. Early Detection:  Research on biomarkers and imaging techniques to identify dementia at its earliest stages.
  2. Lifestyle Interventions:  Studies on diet, exercise, and cognitive training to prevent or delay dementia onset.
  3. Pharmacological Research:  Investigating new drugs and combinations to treat symptoms or modify disease progression.

2. Challenges and Opportunities in Dementia Research

  1. Complexity of Disease:  Dementia encompasses various types, each with different underlying mechanisms, making it difficult to find one   size   fits   all treatments.
  2. Early Diagnosis:  Identifying dementia in its earliest stages remains challenging, affecting the efficacy of interventions.
  3. Funding and Resources:  Adequate funding for large   scale studies and trials is often limited.
  4. Patient Recruitment:  Recruiting diverse participants for trials can be difficult due to the disease's broad impact and the need for specific criteria.
  5. Opportunities:
  6. Advancements in Genetics:  Utilizing genetic information to tailor treatments and understand disease mechanisms better.
  7. Artificial Intelligence:  Leveraging AI to analyze large datasets and improve diagnostic and predictive models.
  8. Biomarkers:  Developing reliable biomarkers for early detection and monitoring disease progression.
  9. Personalized Medicine:  Tailoring treatments based on individual genetic and lifestyle factors.

   3. Potential and Preventive Strategies

  1. Potential Strategies:
  2. Drug Development:  Continuing to develop and test new pharmacological treatments targeting amyloid   beta, tau proteins, and other disease mechanisms.
  3. Immunotherapy:  Exploring vaccines and monoclonal antibodies to target and clear pathological proteins in the brain.
  4. Neuroprotection:  Investigating compounds that protect brain cells from damage or degeneration.
  5. Preventive Strategies:
  6. Lifestyle Modifications:  Promoting physical activity, a healthy diet, and mental stimulation to potentially reduce the risk of developing dementia.
  7. Cognitive Training:  Encouraging activities that challenge the brain, such as puzzles and learning new skills, to maintain cognitive function.
  8. Social Engagement:  Facilitating social interactions and maintaining strong social networks as they are linked to a lower risk of cognitive decline.
  9. Managing Risk Factors:  Addressing cardiovascular risk factors like hypertension, diabetes, and high cholesterol through lifestyle changes and medications.

CONCLUSION

Understanding the epidemiology of dementia helps in planning and implementing effective public health strategies. Addressing modifiable risk factors, investing in research for better treatments and prevention methods, and improving care and support for those affected are critical steps in managing the growing dementia epidemic. Enhanced awareness and early intervention can significantly impact individuals' quality of life and the broader societal burden of dementia

REFERENCES

  1. M. Baumgart et al. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population   based perspective Alzheimer Dement (2015)
  2. M.F. Folstein et al. “Mini   mental state”. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res (1975)
  3. M.F. Mendez Early   onset Alzheimer disease NeurolClin (2017)
  4. B. Dubois et al. Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria Alzheimer Dement (2016)
  5. R. Sperling et al. The evolution of preclinical Alzheimer's disease: implications for prevention trials Neuron (2014)
  6. G. Roman et al. Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementia Arch Med Res (2012)
  7. B. Olsson et al. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta   analysis Lancet Neurol (2016)
  8. D. Seilhean et al. Frontotemporal lobar degeneration: diversity of FTLD lesions Rev Neurol (Paris) (2013)
  9. G. Sechi et al. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management Lancet Neurol (2007)
  10. S. Afzal et al. Reduced 25   hydroxyvitamin D and risk of Alzheimer's disease and vascular dementia Alzheimer's Dement (2014)
  11. M. Baumgart et al. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population   based perspectiveAlzheimers Dementia (2015)
  12. M.F. Folstein et al. “Mini   mental state”. A practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res (1975)
  13. M.F. Mendez Early   onset Alzheimer diseaseNeurol Clincal (2017)
  14. B. Dubois et al. Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteriaAlzheimers Dement (2016)
  15. R. Sperling et al. The evolution of preclinical alzheimer's disease: implications for prevention trials Neuron  (2014)
  16. G. Roman et al. Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementiaArch Med Res (2012)
  17. B. Olsson et al. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review andmeta   analysisLancet Neurol (2016)
  18. D. Seilhean et al. Frontotemporal lobar degeneration: diversity of FTLD lesions Rev Neurol (Paris)  (2013)
  19. G. Sechi et al. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management Lancet Neurol (2007)
  20. S. Afzal et al. Reduced 25   hydroxyvitamin D and risk of alzheimer's disease and vascular dementia Alzheimers Dementia (2014)

Reference

  1. M. Baumgart et al. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population   based perspective Alzheimer Dement (2015)
  2. M.F. Folstein et al. “Mini   mental state”. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res (1975)
  3. M.F. Mendez Early   onset Alzheimer disease NeurolClin (2017)
  4. B. Dubois et al. Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria Alzheimer Dement (2016)
  5. R. Sperling et al. The evolution of preclinical Alzheimer's disease: implications for prevention trials Neuron (2014)
  6. G. Roman et al. Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementia Arch Med Res (2012)
  7. B. Olsson et al. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta   analysis Lancet Neurol (2016)
  8. D. Seilhean et al. Frontotemporal lobar degeneration: diversity of FTLD lesions Rev Neurol (Paris) (2013)
  9. G. Sechi et al. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management Lancet Neurol (2007)
  10. S. Afzal et al. Reduced 25   hydroxyvitamin D and risk of Alzheimer's disease and vascular dementia Alzheimer's Dement (2014)
  11. M. Baumgart et al. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population   based perspectiveAlzheimers Dementia (2015)
  12. M.F. Folstein et al. “Mini   mental state”. A practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res (1975)
  13. M.F. Mendez Early   onset Alzheimer diseaseNeurol Clincal (2017)
  14. B. Dubois et al. Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteriaAlzheimers Dement (2016)
  15. R. Sperling et al. The evolution of preclinical alzheimer's disease: implications for prevention trials Neuron  (2014)
  16. G. Roman et al. Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementiaArch Med Res (2012)
  17. B. Olsson et al. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review andmeta   analysisLancet Neurol (2016)
  18. D. Seilhean et al. Frontotemporal lobar degeneration: diversity of FTLD lesions Rev Neurol (Paris)  (2013)
  19. G. Sechi et al. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management Lancet Neurol (2007)
  20. S. Afzal et al. Reduced 25   hydroxyvitamin D and risk of alzheimer's disease and vascular dementia Alzheimers Dementia (2014)

Photo
Mansi Kotkar
Corresponding author

Arihant College of Pharmacy, Ahilyanagar

Photo
Sakshi Pathak
Co-author

Arihant College of Pharmacy, Ahilyanagar

Photo
Swapnil Kale
Co-author

Arihant College of Pharmacy, Ahilyanagar

Mansi Kotkar*, Sakshi Pathak, Swapnil Kale, The Science of Dementia: Insights into Pathophysiology and Patient Care, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 11, 1716-1727. https://doi.org/10.5281/zenodo.14249474

More related articles
Effect Of Different Flavouring Agents In Drug Pala...
Sujal S. Shete, Tanvi T. Bhosale , Tejashri V. kamble , Nilesh B....
Various Methods Of Phytoconstituent Estimation...
Raviraj Pawar , Vaibhav Paymal , Jaya Kambale, Dr. Nilesh Choug...
Unraveling The Neurobiological Mechanisms And Ther...
Arnab Roy, Prof. (Dr) K. Rajeswar Dutt, Maheswar Prasad Deep, Abr...
Formulation And Evaluation Of Polyherbal Hair Oil...
Namita Sagvekar, , Aishwarya Kocharekar, Gauri Patki, Swapnali Gawas, ...
Design And Characterization Of In Situ Gel Formulations...
Ankit Arun Kumar Jaiswal, Harshada Shankar Chavan, Ashwini Bhimashankar Karnakoti, Dr. Amol Borade, ...
A Systematic Review On Production Of Bio Ethanol From Waste Fruits And Peels...
Ankita Marotrao Deshmukh, Shivani Tawade, Deepika Viswas, Siddhi Vyas, ...
Related Articles
Formulation And Evaluation Of Herbal Lip Balm From Pomegranate Peel Extract...
ABHISHEK VIJAY PAWAR, Nilesh Ashok Lade, Pushpak Bhagchand Liddad, Yashoda R. Suryawanshi , ...
A Review for Resealed erythrocytes as a carrier for drug targeting...
Aishwarya Mahaveer Ingrole , Bhartesh Shirdhone, Shrushti ingrole, Sardar Shelake, Nilesh Chougule, ...
Pharmacological Action Of Polyherbal Gel For Wound Healing Activity On Albino W...
Shardul D Wadkar, Prachi Wavhal, Aarti Buchude, Yash Wayal, Abhishek Walunj, Nikita Bhapkar , Umesh ...
Effect Of Different Flavouring Agents In Drug Palatability Rate Or Sale...
Sujal S. Shete, Tanvi T. Bhosale , Tejashri V. kamble , Nilesh B. Chougule, ...
More related articles
Effect Of Different Flavouring Agents In Drug Palatability Rate Or Sale...
Sujal S. Shete, Tanvi T. Bhosale , Tejashri V. kamble , Nilesh B. Chougule, ...
Various Methods Of Phytoconstituent Estimation...
Raviraj Pawar , Vaibhav Paymal , Jaya Kambale, Dr. Nilesh Chougule, ...
Unraveling The Neurobiological Mechanisms And Therapeutic Challenges In Anxiety ...
Arnab Roy, Prof. (Dr) K. Rajeswar Dutt, Maheswar Prasad Deep, Abrarul Haque, Archana Rani, Nahida Kh...
Effect Of Different Flavouring Agents In Drug Palatability Rate Or Sale...
Sujal S. Shete, Tanvi T. Bhosale , Tejashri V. kamble , Nilesh B. Chougule, ...
Various Methods Of Phytoconstituent Estimation...
Raviraj Pawar , Vaibhav Paymal , Jaya Kambale, Dr. Nilesh Chougule, ...
Unraveling The Neurobiological Mechanisms And Therapeutic Challenges In Anxiety ...
Arnab Roy, Prof. (Dr) K. Rajeswar Dutt, Maheswar Prasad Deep, Abrarul Haque, Archana Rani, Nahida Kh...